A small single-arm trial found preliminary platelet-recovery activity and no serious adverse events among 37 Chinese patients ...
Anti-CD36 alloimmunization may contribute to severe platelet transfusion refractoriness despite negative human leukocyte ...
A new review in Supportive Care in Cancer reframes chemotherapy-induced thrombocytopenia as a dual destruction of ...
Aspirin is about as ordinary as medicine gets, which is part of why a new dementia finding is turning heads. The idea that such a familiar pill might help prevent dementia is intriguing. What makes ...
The U.S. Food and Drug Administration (FDA) on Tuesday approved GSK plc’s GSK Hibsago (bepirovirsen) injection to treat adult ...
ABP News on MSN
US FDA approves new hepatitis B treatment: Can patients finally stop taking antivirals?
The US Food and Drug Administration (FDA) has approved a new treatment for adults with chronic hepatitis B, offering some ...
In its own approval announcement on Oct. 20, the FDA hailed Hibsago as a “first-of-its-kind” treatment in chronic hepatitis B ...
The FDA has approved Hibsago (bepirovirsen) as an add-on antisense oligonucleotide therapy to help noncirrhotic adults with chronic hepatitis B achieve functional cure.
After re-examination, the CHMP confirmed its negative opinion of Yartemlea for HSCT-associated TMA, citing insufficient ...
The U.S. Food and Drug Administration approved GSK plc's Hibsago (bepirovirsen) injection on Tuesday for adults with chronic ...
Nutrition education and encouraging pregnant women to engage in antenatal care are key ways to ensure maternal health and ...
Platelets cannot be manufactured and have a short shelf life, yet can be life-saving in patients undergoing chemotherapy, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results